InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tectonic Therapeutic, Inc.

TECX Clue Score49
United States Fiscal year ends December CIK 0001681087 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

27
Insider
Date
Role
Action
Shares
Price
Amount
Alise Reicin
11 Feb 2026
Chief Executive Officer
Buy
2,500
$21.10
$52.75K
Daniel Lochner
10 Feb 2026
Chief Financial Officer
Buy
6,000
$21.61
$129.66K
Timothy A Springer
11 Apr 2025
Director
Buy indirect
53,706
$16.31
$875.94K
Timothy A Springer
11 Apr 2025
Director
Buy
9,478
$16.31
$154.59K
Timothy A Springer
10 Apr 2025
Director
Buy indirect
45,858
$16.73
$767.20K
Timothy A Springer
10 Apr 2025
Director
Buy
8,092
$16.73
$135.38K
Timothy A Springer
9 Apr 2025
Director
Buy indirect
4,856
$15.23
$73.96K
Timothy A Springer
9 Apr 2025
Director
Buy indirect
16,215
$14.62
$237.06K
Timothy A Springer
9 Apr 2025
Director
Buy
857
$15.23
$13.05K
Timothy A Springer
9 Apr 2025
Director
Buy
2,861
$14.62
$41.83K
Timothy A Springer
7 Apr 2025
Director
Buy indirect
412,500
$17.10
$7.05M
Timothy A Springer
7 Apr 2025
Director
Buy
87,500
$17.10
$1.50M
Daniel Lochner
5 Feb 2025
Chief Financial Officer
Buy
4,617
$54.14
$249.96K
Timothy A Springer
5 Feb 2025
Director
Buy indirect
660,000
$50.00
$33.00M
Timothy A Springer
5 Feb 2025
Director
Buy
129,294
$54.14
$7.00M
Timothy A Springer
22 Oct 2024
Director
Buy
300,000
$33.59
$10.08M
Timothy A Springer
26 Sep 2024
Director
Buy
2,400
$30.87
$74.09K
Timothy A Springer
26 Sep 2024
Director
Buy
4,070
$30.10
$122.51K
Timothy A Springer
26 Sep 2024
Director
Buy
18,999
$29.13
$553.44K
Timothy A Springer
26 Sep 2024
Director
Buy
24,531
$28.16
$690.79K
Braden Michael Leonard
14 May 2024
10% owner
Buy indirect
296,882
$1.30
$385.95K
Braden Michael Leonard
13 May 2024
10% owner
Buy indirect
216,053
$1.26
$272.23K
Braden Michael Leonard
13 May 2024
10% owner
Buy indirect
253,700
$1.24
$313.32K
Philip J. Vickers
7 Jul 2021
Director
Buy
4,800
$8.35
$40.08K
Phillip B. Donenberg
17 Feb 2021
Director
Buy
2,000
$11.71
$23.42K
Bruce Booth
19 Jul 2019
Director
Buy indirect
810,811
$18.50
$15.00M
Atlas Venture Fund X, L.P.
19 Jul 2019
10% owner
Buy indirect
810,811
$18.50
$15.00M
Show all 62 transactions →

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 5
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 32,689,931
Sales filed before the plan box existed 11
History held since 22 Jun 2018